Ionis Pharmaceuticals, Inc.
MX ˙ BMV ˙ US4622221004
SecurityMX:IONS / Ionis Pharmaceuticals, Inc.
InstitutionProShare Advisors LLC
Latest Disclosed Ownership7,390 shares
Latest Disclosed Value $ 554,915
ProShare Advisors LLC reports 3.30% increase in ownership of IONS / Ionis Pharmaceuticals, Inc.

On April 24, 2026 - ProShare Advisors LLC filed a 13F-HR form disclosing ownership of 7,390 shares of Ionis Pharmaceuticals, Inc. (MX:IONS) valued at $554,915 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 7,154 shares of Ionis Pharmaceuticals, Inc.. This represents a change in shares of 3.30% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-03-31 13F IONIS PHARMACEUTICALS COM 462222100 7,390 236 3.30 555 -1.95 0.0008
2026-02-06 2025-12-31 13F IONIS PHARMACEUTICALS COM 462222100 7,154 1,476 26.00 566 52.29 0.0010
2025-11-06 2025-09-30 13F IONIS PHARMACEUTICALS COM 462222100 5,678 -265 -4.46 371 58.55 0.0008
2025-08-07 2025-06-30 13F IONIS PHARMACEUTICALS COM 462222100 5,943 -1,228 -17.12 235 8.33 0.0005
2025-05-08 2025-03-31 13F IONIS PHARMACEUTICALS COM 462222100 7,171 -309 -4.13 216 -17.24 0.0005
2025-02-14 2024-12-31 13F IONIS PHARMACEUTICALS COM 462222100 7,480 -1,160 -13.43 262 -24.57 0.0006
2024-11-14 2024-09-30 13F IONIS PHARMACEUTICALS COM 462222100 8,640 -371 -4.12 346 -19.35 0.0008
2024-08-13 2024-06-30 13F IONIS PHARMACEUTICALS COM 462222100 9,011 -1,205 -11.80 429 -2.94 0.0011
2024-05-08 2024-03-31 13F IONIS PHARMACEUTICALS COM 462222100 10,216 1,049 11.44 443 -4.54 0.0012
2024-02-14 2023-12-31 13F IONIS PHARMACEUTICALS COM 462222100 9,167 -203 -2.17 464 8.94 0.0014
2023-11-13 2023-09-30 13F IONIS PHARMACEUTICALS COM 462222100 9,370 112 1.21 425 12.14 0.0013
2023-08-10 2023-06-30 13F IONIS PHARMACEUTICALS COM 462222100 9,258 -653 -6.59 380 7.06 0.0011
2023-05-26 2023-03-31 13F/A-1 IONIS PHARMACEUTICALS COM 462222100 9,911 -3,992 -28.71 354 -32.57 0.0011
2023-05-12 2023-03-31 13F IONIS PHARMACEUTICALS COM 462222100 9,911 -3,992 354 0.0011
2023-02-02 2022-12-31 13F IONIS PHARMACEUTICALS COM 462222100 13,903 -295 -2.08 525 -16.40 0.0018
2022-11-07 2022-09-30 13F IONIS PHARMACEUTICALS COM 462222100 14,198 831 6.22 628 26.87 0.0024
2022-08-01 2022-06-30 13F IONIS PHARMACEUTICALS COM 462222100 13,367 -4,534 -25.33 495 -25.34 0.0016
2022-05-10 2022-03-31 13F IONIS PHARMACEUTICALS COM 462222100 17,901 -5,531 -23.60 663 -7.01 0.0014
2022-02-08 2021-12-31 13F IONIS PHARMACEUTICALS COM 462222100 23,432 -10,067 -30.05 713 -36.57 0.0014
2021-11-12 2021-09-30 13F IONIS PHARMACEUTICALS COM 462222100 33,499 3,076 10.11 1,124 -7.41 0.0032
2021-08-13 2021-06-30 13F IONIS PHARMACEUTICALS COM 462222100 30,423 8,288 37.44 1,214 22.01 0.0035
2021-05-14 2021-03-31 13F IONIS PHARMACEUTICALS COM 462222100 22,135 -1,955 -8.12 995 -26.95 0.0031
2021-02-09 2020-12-31 13F IONIS PHARMACEUTICALS COM 462222100 24,090 -839 -3.37 1,362 15.13 0.0051
2020-11-13 2020-09-30 13F IONIS PHARMACEUTICALS COM 462222100 24,929 620 2.55 1,183 -17.45 0.0055
2020-08-03 2020-06-30 13F IONIS PHARMACEUTICALS COM 462222100 24,309 2,602 11.99 1,433 39.67 0.0077
2020-05-15 2020-03-31 13F IONIS PHARMACEUTICALS COM 462222100 21,707 -11,769 -35.16 1,026 -49.26 0.0074
2020-02-12 2019-12-31 13F IONIS PHARMACEUTICALS COM 462222100 33,476 -7,564 -18.43 2,022 -17.77 0.0094
2019-11-12 2019-09-30 13F IONIS PHARMACEUTICALS COM 462222100 41,040 -3,341 -7.53 2,459 -13.78 0.0138
2019-08-13 2019-06-30 13F IONIS PHARMACEUTICALS COM 462222100 44,381 -7,907 -15.12 2,852 -32.80 0.0171
2019-05-15 2019-03-31 13F IONIS PHARMACEUTICALS COM 462222100 52,288 1,613 3.18 4,244 54.95 0.0254
2019-02-14 2018-12-31 13F IONIS PHARMACEUTICALS COM 462222100 50,675 -10,154 -16.69 2,739 -12.72 0.0192
2018-11-14 2018-09-30 13F IONIS PHARMACEUTICALS COM 462222100 60,829 5,086 9.12 3,138 35.08 0.0213
2018-08-13 2018-06-30 13F IONIS PHARMACEUTICALS COM 462222100 55,743 -5,436 -8.89 2,323 -13.87 0.0156
2018-05-14 2018-03-31 13F IONIS PHARMACEUTICALS COM 462222100 61,179 -9,419 -13.34 2,697 -24.05 0.0176
2018-02-14 2017-12-31 13F IONIS PHARMACEUTICALS COM 462222100 70,598 -2,407 -3.30 3,551 -4.05 0.0246
2017-11-13 2017-09-30 13F IONIS PHARMACEUTICALS COM 462222100 73,005 6,775 10.23 3,701 9.85 0.0340
2017-08-11 2017-06-30 13F IONIS PHARMACEUTICALS COM 462222100 66,230 -1,039 -1.54 3,369 24.59 0.0336
2017-05-12 2017-03-31 13F/A-2 IONIS PHARMACEUTICALS COM 462222100 67,269 -14,539 -17.77 2,704 -30.90 0.0283
2017-05-08 2017-03-31 13F/A-1 IONIS PHARMACEUTICALS COM 462222100 67,269 0 2,704 0.0283
2017-04-25 2017-03-31 13F IONIS PHARMACEUTICALS COM 462222100 67,269 2,704
2017-02-13 2016-12-31 13F IONIS PHARMACEUTICALS COM 462222100 81,808 2,221 2.79 3,913 34.19 0.0433
2016-11-10 2016-09-30 13F IONIS PHARMACEUTICALS COM 462222100 79,587 -14,326 -15.25 2,916 33.33 0.0407
2016-08-12 2016-06-30 13F IONIS PHARMACEUTICALS COM 462222100 93,913 1,997 2.17 2,187 -41.26 0.0282
2016-05-06 2016-03-31 13F IONIS PHARMACEUTICALS COM 462222100 91,916 -9,179 -9.08 3,723 -40.54 0.0513
2016-02-05 2015-12-31 13F IONIS PHARMACEUTICALS COM 462222100 101,095 5,208 5.43 6,261 61.53 0.0758
2015-11-06 2015-09-30 13F ISIS PHARMACEUTICALS COM 464330109 95,887 -6,291 -6.16 3,876 -34.08 0.0544
2015-08-11 2015-06-30 13F ISIS PHARMACEUTICALS COM 464330109 102,178 -21,857 -17.62 5,880 -25.54 0.0814
2015-05-08 2015-03-31 13F ISIS PHARMACEUTICALS COM 464330109 124,035 124,035 0.00 7,897 0.0930
2015-01-30 2014-12-31 13F ISIS PHARMACEUTICALS COM 464330109 0 -111,129 -100.00 0 -100.00
2014-11-06 2014-09-30 13F ISIS PHARMACEUTICALS COM 464330109 111,129 -22,086 -16.58 4,315 -5.97 0.0572
2014-08-08 2014-06-30 13F ISIS PHARMACEUTICALS COM 464330109 133,215 -73,546 -35.57 4,589 -48.63 0.0595
2014-05-07 2014-03-31 13F ISIS PHARMACEUTICALS COM 464330109 206,761 143,767 228.22 8,934 255.94 0.1117
2014-02-04 2013-12-31 13F ISIS PHARMACEUTICALS COM 464330109 62,994 -51,471 -44.97 2,510 -41.59 0.0374
2013-11-07 2013-09-30 13F ISIS PHARMACEUTICALS COM 464330109 114,465 17,563 18.12 4,297 65.02 0.1020
2013-07-25 2013-06-30 13F ISIS PHARMACEUTICALS COM 464330109 96,902 96,902 2,604 0.0511
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.